Remnant cholesterol and long-term incidence of death in coronary artery disease patients
Open accessAbstract
Background Remnant cholesterol (RC), defined as non-HDL-non-LDL cholesterol, has attracted recent scientific interest as a candidate lipid factor for residual cardiovascular risk. Despite a rising amount of epidemiologic information, there are imprecisions because most available data arise from non-fasting, frozen and calculated values. Methods We enrolled 1474 consecutive patients with angiographically proven CAD, and measured RC in strictly fasting, non-frozen samples with a direct assay for LDL-C. Prospectively, all-cause mortality, cardiovascular mortality, and major adverse cardiovascular events (MACE) were recorded over a mean follow-up period of 11.6 ± 5.0 years, covering 17098 patient years. Results During follow-up, CAD patients had a rate of all-cause mortality of 52.2 % (n = 769), of cardiovascular mortality of 20.6 % (n = 303), and an incidence of major adverse cardiovascular events (MACE) of 39.1 % (n = 576). Prospectively, RC was associated with all-cause mortality (HR 1.12 [1.03-1.23], p = 0.009), cardiovascular mortality (HR 1.20 [1.06-1.36], p = 0.005), and MACE (HR 1.10 [1.01-1.21], p = 0.033) in Cox regression analyses across various levels of adjustment (age, sex, smoking, LDL-C, HDL-C, hypertension, T2DM, and BMI). Findings did not differ between women and men. Furthermore, there was no discernible influence of statin treatment. Conclusions From our data we conclude that RC is associated with future all-cause mortality, cardiovascular mortality and MACE i…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Observational cohorts demonstrate that higher TG and remnant cholesterol predict cardiovascular events independently of LDL-C.
“Observational cohorts demonstrate that higher TG and remnant cholesterol predict cardiovascular events independently of LDL-C, while Mendelian randomization analyses confirm a causal relationship between lifelong TRL elevation and ASCVD.”
From Targeting triglycerides for cardiovascular risk reduction (2026) · cites this paper as [41]
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603 · see citing works
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961 · see citing works
Self-citation2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D. M., et al. (2022) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,652 · see citing works
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
Pencina, M. J., D’Agostino, R. B., & Steyerberg, E. W. (2010) · Statistics in Medicine · doi:10.1002/sim.4085 · Cited by 2,478 · see citing works
Lawton, J. S., Tamis-Holland, J. E., Bangalore, S., Bates, E. R., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., et al. (2021) · Circulation · doi:10.1161/cir.0000000000001038 · Cited by 1,328 · see citing works
Chapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr112 · Cited by 1,227 · see citing works
Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
Varbo, A., Benn, M., Tybjærg-Hansen, A., Jørgensen, A. B., Frikke-Schmidt, R., & Nordestgaard, B. G. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.1026 · Cited by 1,115 · see citing works
Ginsberg, H. N., Packard, C. J., Chapman, M. J., Borén, J., Aguilar-Salinas, C. A., Averna, M., Ference, B. A., Gaudet, D., Hegele, R. A., Kersten, S., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab551 · Cited by 979 · see citing works
Varbo, A., Benn, M., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2013) · Circulation · doi:10.1161/circulationaha.113.003008 · Cited by 692 · see citing works
Sandesara, P. B., Virani, S. S., Fazio, S., & Shapiro, M. D. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00184 · Cited by 626 · see citing works
JBS3 Board (2014) · Heart · doi:10.1136/heartjnl-2014-305693 · Cited by 608 · see citing works
Bosco, E., Hsueh, L., McConeghy, K. W., Gravenstein, S., & Saade, E. A. (2021) · BMC Medical Research Methodology · doi:10.1186/s12874-021-01440-5 · Cited by 581 · see citing works
Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease
Castañer, O., Pintó, X., Subirana, I., Amor, A. J., Ros, E., Hernáez, Á., Martínez-González, M. Á., Corella, D., Salas-Salvadó, J., Estruch, R., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.10.008 · Cited by 540 · see citing works
Borén, J., & Williams, K. J. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000330 · Cited by 524 · see citing works
Martin, S. S., Blaha, M. J., Elshazly, M. B., Brinton, E. A., Toth, P. P., McEvoy, J. W., Joshi, P. H., Kulkarni, K. R., Mize, P. D., Kwiterovich, P. O., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.079 · Cited by 428 · see citing works
Bachorik, P. S., & Ross, J. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.10.1414 · Cited by 412 · see citing works
Uno, H., Tian, L., Cai, T., Kohane, I. S., & Wei, L. J. (2012) · Statistics in Medicine · doi:10.1002/sim.5647 · Cited by 386 · see citing works
DeLong, D. M. (1986) · JAMA · doi:10.1001/jama.1986.03380170088024 · Cited by 299 · see citing works
Jepsen, A.-M. K., Langsted, A., Varbo, A., Bang, L. E., Kamstrup, P. R., & Nordestgaard, B. G. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2015.253757 · Cited by 218 · see citing works
Wadström, B. N., Pedersen, K. M., Wulff, A. B., & Nordestgaard, B. G. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac822 · Cited by 209 · see citing works
Varbo, A., Freiberg, J. J., & Nordestgaard, B. G. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.234146 · Cited by 209 · see citing works
Saely, C. H., Aczél, S., Marte, T., Langer, P. H., Hoefle, G., & Drexel, H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0799 · Cited by 191 · see citing works
Self-citationJoshi, P. H., Khokhar, A. A., Massaro, J. M., Lirette, S. T., Griswold, M. E., Martin, S. S., Blaha, M. J., Kulkarni, K. R., Correa, A., D'Agostino, R. B., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002765 · Cited by 177 · see citing works
Saeed, A., Feofanova, E. V., Yu, B., Sun, W., Virani, S. S., Nambi, V., Coresh, J., Guild, C., Boerwinkle, E., Ballantyne, C. M., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.050 · Cited by 174 · see citing works
Drexel, H., Aczél, S., Marte, T., Benzer, W., Langer, P. H., Moll, W., & Saely, C. H. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.101 · Cited by 161 · see citing works
Self-citationEffects of sample handling and storage on quantitative lipid analysis in human serum
Zivkovic, A. M., Wiest, M. M., Nguyen, U. T., Davis, R., Watkins, S. M., & German, J. B. (2009) · Metabolomics · doi:10.1007/s11306-009-0174-2 · Cited by 154 · see citing works
Postprandial Hyperlipidemia and Remnant Lipoproteins
Masuda, D., & Yamashita, S. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv16003 · Cited by 145 · see citing works
Varbo, A., Freiberg, J. J., & Nordestgaard, B. G. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.279463 · Cited by 133 · see citing works
Elevated Remnant Cholesterol Reclassifies Risk of Ischemic Heart Disease and Myocardial Infarction
Doi, T., Langsted, A., & Nordestgaard, B. G. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.03.384 · Cited by 129 · see citing works
Remnant Cholesterol and Atherosclerotic Cardiovascular Disease Risk
Burnett, J. R., Hooper, A. J., & Hegele, R. A. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.10.029 · Cited by 119 · see citing works
What is ‘remnant cholesterol’?
Stürzebecher, P. E., Katzmann, J. L., & Laufs, U. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac783 · Cited by 116 · see citing works
Cao, Y., Zhang, H., Jin, J., Liu, H., Zhang, Y., Gao, Y., Guo, Y., Wu, N., Hua, Q., Li, Y., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01076-7 · Cited by 98 · see citing works
Zheng, X., & Liu, L. (2007) · Journal of Lipid Research · doi:10.1194/jlr.r700001-jlr200 · Cited by 97 · see citing works
Remnant lipoproteins: are they equal to or more atherogenic than LDL?
Salinas, C. A. A., & Chapman, M. J. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000682 · Cited by 87 · see citing works
Qian, S., You, S., Sun, Y., Wu, Q., Wang, X., Tang, W., Dong, X., Liu, C.-F., Xu, T., Cao, Y., et al. (2021) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.120.010953 · Cited by 86 · see citing works
Yang, X. H., Zhang, B. L., Cheng, Y., Fu, S. K., & Jin, H. M. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.03.012 · Cited by 81 · see citing works
Doi, T., Langsted, A., & Nordestgaard, B. G. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.05.010 · Cited by 74 · see citing works
Liu, L., Wen, T., Zheng, X., Yang, D., Zhao, S., Xu, D., & Lü, G. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.05.024 · Cited by 55 · see citing works
Gao, S., Xu, H., Ma, W., Yuan, J., & Yu, M. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024366 · Cited by 47 · see citing works
Saleh, A., Makhamreh, H., Qoussoos, T., AlAwwa, I., Alsmady, M., Salah, Z. A., Shakhatreh, A., Alhazaymeh, L., & Jabber, M. (2018) · Medicine · doi:10.1097/md.0000000000011519 · Cited by 46 · see citing works
Drexel, H., LARCHER, B., MADER, A., Vonbank, A., Heinzle, C. F., Moser, B., Zanolin-Purin, D., & Saely, C. H. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.05.010 · Cited by 45 · see citing works
Self-citationCartier, L.-J., Collins, C., Lagacé, M., & Douville, P. (2018) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.11.007 · Cited by 44 · see citing works
Chevli, P. A., Islam, T., Pokharel, Y., Rodríguez, F., Virani, S. S., Blaha, M. J., Bertoni, A. G., Budoff, M. J., Otvos, J. D., & Shapiro, M. D. (2022) · Journal of clinical lipidology · doi:10.1016/j.jacl.2022.09.005 · Cited by 38 · see citing works
Holzer, M., Kern, S., Trieb, M., Trakaki, A., & Marsche, G. (2017) · Journal of Lipid Research · doi:10.1194/jlr.d075366 · Cited by 33 · see citing works
Drexel, H., Tamargo, J. L., Kaski, J. C., Lewis, B. S., Saely, C. H., Fraunberger, P., Dobrev, D., Komiyama, M., PLATTNER, T., Agewall, S., et al. (2023) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvad044 · Cited by 29 · see citing works
Self-citationNakajima, K., Nakajima, Y., Takeichi, S., & Fujita, M. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.09.016 · Cited by 27 · see citing works
Mangat, R., Warnakula, S., Borthwick, F., Hassanali, Z., Uwiera, R. R. E., Russell, J. C., Cheeseman, C. I., Vine, D. F., & Proctor, S. D. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.003434 · Cited by 26 · see citing works
Zimerman, A., Wiviott, S. D., Park, J., Murphy, S. A., Ran, X., Bramson, C., Curto, M., Ramos, V., Jevne, A., Kuder, J., et al. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae090 · Cited by 26 · see citing works
Drexel, H., Rosano, G. M. C., Lewis, B. S., Huber, K., Vonbank, A., Dopheide, J. F., MADER, A., Niessner, A., Savarese, G., Waßmann, S., et al. (2019) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvz029 · Cited by 20 · see citing works
Self-citationMink, S., Saely, C. H., Frick, M., Leiherer, A., Drexel, H., & Fraunberger, P. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12155068 · Cited by 9 · see citing works
Self-citationLipoprotein remnants: to be or not to be
Pirillo, A., & Catapano, A. L. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab511 · Cited by 7 · see citing works
Cemin, R., Casablanca, S., Ermacora, D., & Daves, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134422 · Cited by 5 · see citing works
25 years of lipid-lowering therapy: secular trends in therapy of coronary patients
Ratz, M., Vogel, J. B., Kuehrer, H., Säly, C., Mündlein, A., Vonbank, A., MADER, A., Fraunberger, P., Leiherer, A., & Drexel, H. (2024) · Wiener klinische Wochenschrift · doi:10.1007/s00508-024-02365-x · Cited by 4 · see citing works
Self-citation
Flagged first, then by citations
1 of the 54 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Hou, Y., Tian, P., Song, G., Song, A., Liu, D., Wang, Z., Shi, Y., Tang, Y., Wang, X., Li, L., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1502792 · Cited by 4 · see citing works
Yang, Z., Niu, L., Zhao, Y., Cao, X., Wang, L., Zhao, Q., Fan, J., & Wang, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-32281-7 · Cited by 2 · see citing works
Yin, X., Zhang, Y., & Ren, L. (2025) · International Heart Journal · doi:10.1536/ihj.24-618 · Cited by 1 · see citing works
Jian, G., Wang, Z., Wang, J., Lan, H., Jiang, K., Lu, Z., Sheng, G., Xie, G., Wang, W., Zou, Y., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1792583 · Cited by 1 · see citing works
Mercola, J. M. (2025) · World Journal of Cardiology · doi:10.4330/wjc.v17.i8.110163 · Cited by 1 · see citing works
Management of dyslipidaemia in patients with comorbidities—facing the challenge: heart failure
Drexel, H., Frick, M., Zirlik, A., Niessner, A., Huber, K., Tamargo, J., Dobrev, D., MADER, A., & Agewall, S. (2026) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvag033 · Cited by 1 · see citing works
Self-citationSex-specific disparities in lipid-based prediction of major cardiovascular events
SCHNETZER, L., Muendlein, A., Festa, A., Saely, C. H., Drexel, H., & Leiherer, A. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf646 · Cited by 1 · see citing works
Self-citationRemnant Cholesterol: A Missed Opportunity in Cardiovascular Risk Reduction?
de Carvalho, L. S. F., & Barros, R. D. O. G. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119129 · Cited by 1 · see citing works
Targeting triglycerides for cardiovascular risk reduction
Maiorca, C., Tramontano, D., Di Costanzo, A., & D’Erasmo, L. (2026) · Internal and Emergency Medicine · doi:10.1007/s11739-026-04383-1
Chen, F., Zeng, C., Guo, H., Tian, N., Xu, Q., Zhan, X., Peng, F., Wang, X., Su, N., Feng, X., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6590878/v1
Gan, H., Gao, K., Li, Z., Zhang, Y., Li, L., Li, Y., & Guo, H. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1772328
(Liver steatosis as a risk of coronary heart disease)
Poledne, R., Pajuelo, D., & Lesná, I. K. (2025) · Cor et Vasa · doi:10.33678/cor.2025.116
Li, W., Gao, K., Zhang, H., Xia, W., Balajiang, B., Wang, H., & Tong, X. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-05766-0
Fan, Y., Lu, Y., Fan, X., Wu, Y., & Wang, Y. (2026) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-026-09031-2
Tang, L. L., Yang, H. U. I., Yang, Y.-J., Hu, X.-Q., Fang, Z.-F., Liao, X., Xiao, Y.-C., Yang, H. U. I., Zhu, Z.-W., & Zhou, S.-H. (2026) · European journal of medical research · doi:10.1186/s40001-026-04454-1
Pei, Y., Liu, B., & Gu, Y. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.07.018
The Role of Triglycerides in the Development of Atherosclerosis
Cerebiejūtė, V., Girkantaitė, Ž., Rinkūnienė, E., Gimžauskaitė, S., & Badarienė, J. (2026) · Acta medica Lituanica · doi:10.15388/amed.2026.33.1.4
Yue, S., Chen, H., Zheng, J., Wang, J., & Lu, B. (2026) · Archives of Medical Science · doi:10.5114/aoms/221685
Chen, X., Li, Y., 马建伟, Song, G., Chai, Y., Li, C., Yin, Y., Yan, Y., Zheng, M., & Ma, F. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1904167
- Authors
- Drexel, H., Mader, A., Larcher, B., Festa, A., Vonbank, A., Fraunberger, P., Leiherer, A., & Saely, C. H.
- Affiliations
- Private University in the Principality of Liechtenstein (LI)
- Landeskrankenhaus Feldkirch (AT)
- Corresponding author
- Drexel, Heinz
- ORCID
- Venue
- Atherosclerosis
- Publisher
- Elsevier BV
- Published
- 2025-02
- Volume
- 401
- Pages
- 119048
- ISSN
- 0021-9150 (ISSN-L)
- OpenAlex
- W4404437443
- Cited by
- 17
- References
- 54
- Citations by year
- 2026: 9 · 2025: 8
- FWCI
- 7.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Atherosclerosis (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- remnant cholesterol, coronary artery disease, all-cause mortality, cardiovascular mortality, major adverse cardiovascular events, residual cardiovascular risk, non-HDL cholesterol, LDL cholesterol, statin therapy, long-term prognosis
- MeSH terms
- Aged, Cause of Death, Cholesterol, Coronary Artery Disease, Female, Humans, Lipoproteins, Cholesterol, LDL, Male, Middle Aged, Prospective Studies, Risk Factors, Time Factors, Triglycerides, Biomarkers, Incidence, Proportional Hazards Models, Coronary Angiography, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review